MedPath

A controlled ,Prospective Study of the Effects of statins on Progression of diabetic nephropathy

Not Applicable
Conditions
diabetic nephropathy
Registration Number
JPRN-UMIN000001774
Lead Sponsor
Fukuiken-Saiseikai Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

1 While person take statins, or statins administration is done one within three months 2 160/100mm Hg is more than most recent twice sphygmomanometry value together the one where blood pressure control is poor 3 Drifting for three months is higher than 2% more than most recent HbA1c10% recently the one where glycemic control states are defectiveness or insecurity 4 The one that presents nephrotic syndrome 5 The person who judged that others, a family doctor were inadequate 6 Others, Dr.clinical study liability or Dr.clinical study allotment is this clinical study which they intend for it and judged to be inadequate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath